These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 23583659)
41. Striatal long noncoding RNA Abhd11os is neuroprotective against an N-terminal fragment of mutant huntingtin in vivo. Francelle L; Galvan L; Gaillard MC; Petit F; Bernay B; Guillermier M; Bonvento G; Dufour N; Elalouf JM; Hantraye P; Déglon N; de Chaldée M; Brouillet E Neurobiol Aging; 2015 Mar; 36(3):1601.e7-16. PubMed ID: 25619660 [TBL] [Abstract][Full Text] [Related]
44. Rhes depletion promotes striatal accumulation and aggregation of mutant huntingtin in a presymptomatic HD mouse model. Pan Y; Tang B; Li XJ; Li S; Liu Q Front Aging Neurosci; 2023; 15():1237018. PubMed ID: 37637962 [TBL] [Abstract][Full Text] [Related]
45. Progressive and selective striatal degeneration in primary neuronal cultures using lentiviral vector coding for a mutant huntingtin fragment. Zala D; Benchoua A; Brouillet E; Perrin V; Gaillard MC; Zurn AD; Aebischer P; Déglon N Neurobiol Dis; 2005 Dec; 20(3):785-98. PubMed ID: 16006135 [TBL] [Abstract][Full Text] [Related]
46. Deficiency of Ube3a in Huntington's disease mice brain increases aggregate load and accelerates disease pathology. Maheshwari M; Shekhar S; Singh BK; Jamal I; Vatsa N; Kumar V; Sharma A; Jana NR Hum Mol Genet; 2014 Dec; 23(23):6235-45. PubMed ID: 25027318 [TBL] [Abstract][Full Text] [Related]
47. Expression, pharmacology and functional activity of adenosine A1 receptors in genetic models of Huntington's disease. Ferrante A; Martire A; Pepponi R; Varani K; Vincenzi F; Ferraro L; Beggiato S; Tebano MT; Popoli P Neurobiol Dis; 2014 Nov; 71():193-204. PubMed ID: 25132555 [TBL] [Abstract][Full Text] [Related]
48. Rhes Tunnels: A Radical New Way of Communication in the Brain's Striatum? Subramaniam S Bioessays; 2020 Jun; 42(6):e1900231. PubMed ID: 32236969 [TBL] [Abstract][Full Text] [Related]
49. Mitigation of augmented extrasynaptic NMDAR signaling and apoptosis in cortico-striatal co-cultures from Huntington's disease mice. Milnerwood AJ; Kaufman AM; Sepers MD; Gladding CM; Zhang L; Wang L; Fan J; Coquinco A; Qiao JY; Lee H; Wang YT; Cynader M; Raymond LA Neurobiol Dis; 2012 Oct; 48(1):40-51. PubMed ID: 22668780 [TBL] [Abstract][Full Text] [Related]
50. Striatum specific protein, Rhes regulates AKT pathway. Bang S; Steenstra C; Kim SF Neurosci Lett; 2012 Jul; 521(2):142-7. PubMed ID: 22683505 [TBL] [Abstract][Full Text] [Related]
51. Early and reversible neuropathology induced by tetracycline-regulated lentiviral overexpression of mutant huntingtin in rat striatum. Régulier E; Trottier Y; Perrin V; Aebischer P; Déglon N Hum Mol Genet; 2003 Nov; 12(21):2827-36. PubMed ID: 12952868 [TBL] [Abstract][Full Text] [Related]
52. The RAGE receptor and its ligands are highly expressed in astrocytes in a grade-dependant manner in the striatum and subependymal layer in Huntington's disease. Kim J; Waldvogel HJ; Faull RL; Curtis MA; Nicholson LF J Neurochem; 2015 Sep; 134(5):927-42. PubMed ID: 26011179 [TBL] [Abstract][Full Text] [Related]
53. RasGRP1 promotes amphetamine-induced motor behavior through a Rhes interaction network ("Rhesactome") in the striatum. Shahani N; Swarnkar S; Giovinazzo V; Morgenweck J; Bohn LM; Scharager-Tapia C; Pascal B; Martinez-Acedo P; Khare K; Subramaniam S Sci Signal; 2016 Nov; 9(454):ra111. PubMed ID: 27902448 [TBL] [Abstract][Full Text] [Related]
54. The impairment of cholesterol metabolism in Huntington disease. Leoni V; Caccia C Biochim Biophys Acta; 2015 Aug; 1851(8):1095-105. PubMed ID: 25596342 [TBL] [Abstract][Full Text] [Related]
56. Rhes, a striatal-enriched protein, promotes mitophagy via Nix. Sharma M; Ramírez Jarquín UN; Rivera O; Kazantzis M; Eshraghi M; Shahani N; Sharma V; Tapia R; Subramaniam S Proc Natl Acad Sci U S A; 2019 Nov; 116(47):23760-23771. PubMed ID: 31676548 [TBL] [Abstract][Full Text] [Related]
57. Huntingtin localization in brains of normal and Huntington's disease patients. Sapp E; Schwarz C; Chase K; Bhide PG; Young AB; Penney J; Vonsattel JP; Aronin N; DiFiglia M Ann Neurol; 1997 Oct; 42(4):604-12. PubMed ID: 9382472 [TBL] [Abstract][Full Text] [Related]
58. Rhes deletion is neuroprotective in the 3-nitropropionic acid model of Huntington's disease. Mealer RG; Subramaniam S; Snyder SH J Neurosci; 2013 Feb; 33(9):4206-10. PubMed ID: 23447628 [TBL] [Abstract][Full Text] [Related]
59. Proteasome activator enhances survival of Huntington's disease neuronal model cells. Seo H; Sonntag KC; Kim W; Cattaneo E; Isacson O PLoS One; 2007 Feb; 2(2):e238. PubMed ID: 17327906 [TBL] [Abstract][Full Text] [Related]
60. Mitochondrial fragmentation in neuronal degeneration: Toward an understanding of HD striatal susceptibility. Cherubini M; Ginés S Biochem Biophys Res Commun; 2017 Feb; 483(4):1063-1068. PubMed ID: 27514446 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]